中文 | English
Return
Total: 219 , 1/22
Show Home Prev Next End page: GO
Author:(Lingyun LI)

1.Research progress of glypican 3: a marker for hepatocellular carcinoma

Lingyun LI

Journal of International Oncology 2008;35(4):294-296

2.Early prediction of breast cancer

Lingyun HU ; Yali LI

Journal of International Oncology 2011;38(2):118-120

3.Trans-scleral ocular drug delivery for the treatment of posterior segment eye diseases

Xiaoli LI ; Lingyun CHENG

Chinese Journal of Ocular Fundus Diseases 2017;33(2):213-217

4.Application of iopromide in hysterosalpingography

Xiaolan LI ; Lingyun LIANG ; Junqi MA

Journal of Practical Radiology 2015;(1):106-109

5.The use and future of transgenic animals in pharmacological research

Lingyun LI ; Ting WANG ; Guoxiang CHENG ;

Chinese Pharmacological Bulletin 1987;0(03):-

6.Function of myocardial cellular membrane after retrograde sinus coronary perfusion in isolated rabbit hearts

Fuping LI ; Yingbin XIAO ; Lingyun GAO ;

Journal of Third Military Medical University 2003;0(14):-

7.Isolated behavior and related factors of chronic obstructive pulmonary disease patients

Lingyun GAO ; Hongxiang ZENG ; Lina LI

Chinese Journal of Behavioral Medicine and Brain Science 2008;17(8):705-706

8.Clinical Observations on Combined Acupuncture and Medicine for the Treatment of Kidney Deficiency and Phlegm ;Dampness Syndrome in Obese Polycystic Ovary Syndrome

Lingyun ZHOU ; Chuanhua XU ; Shuping LI

Shanghai Journal of Acupuncture and Moxibustion 2016;35(10):1213-1215

9.A study about the proper braking and bed rest time for patients with TACE operation

Xinzhi SHAN ; Yinglan LI ; Lingyun ZHANG

Chinese Journal of Practical Nursing 2006;0(18):-

10.Combination of adenovirus-mediated endostatin gene and chemotherapy in treatment of Lewis lung cancer in mice

Lingyun MA ; Qiang LI ; Zhongling LIU

Academic Journal of Second Military Medical University 2000;0(07):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 219 , 1/22 Show Home Prev Next End page: GO